No association between migraine and breast cancer risk
the ONA take:
According to a new study published in the Journal of the National Cancer Institute, researchers at Harvard University Medical School in Boston, Massachusetts, have found that there is no associated between migraines and risk of breast cancer.
For the studies, researchers analyzed four other studies that included over 100,000 women actually found that migraines may decrease the risk of breast cancer, but researchers note that this finding may be due to study design rather than a real association.
The theory that there was a link between migraines and risk of breast cancer comes up from the notion that both arise from increased sex hormone levels. When the research team analyzed the levels of sex hormones in about 2,000 premenopausal women who experience migraines, the researchers found no link between the two.
According to the Migraine Research Foundation, approximately 18% of American women and 6% of American men experience migraines. A migraine is a severe headache that is often accompanied by sensitivity to light and sound, nausea, visual disturbances, and vomiting. A migraine can last anywhere between 4 hour and 3 days.
There is no associated between migraines and risk of breast cancer.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- High Symptom Burden With Polycythemia Vera Linked to QoL Impairment
- Bioimpedence Spectroscopy Improves Early Detection of Breast Cancer-Related Lymphedema in At-Risk Patients
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- MRD Negativity Associated With Prolonged Survival in Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Patient Navigation Reduces Delays in Diagnostic Resolution
- Fee-for-service Medicare Plans Linked to Improved Care During Last Year of Life
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|